These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 22947592)
1. Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on risk of atrial fibrillation before coronary artery bypass grafting. Johnston K; Stephens S Ann Pharmacother; 2012 Sep; 46(9):1239-44. PubMed ID: 22947592 [TBL] [Abstract][Full Text] [Related]
2. Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting. Bandeali SJ; Kayani WT; Lee VV; Pan W; Elayda MA; Nambi V; Jneid HM; Alam M; Wilson JM; Birnbaum Y; Ballantyne CM; Virani SS Am J Cardiol; 2012 Oct; 110(7):919-23. PubMed ID: 22727178 [TBL] [Abstract][Full Text] [Related]
3. Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III. White CM; Kluger J; Lertsburapa K; Faheem O; Coleman CI Eur J Cardiothorac Surg; 2007 May; 31(5):817-20. PubMed ID: 17350856 [TBL] [Abstract][Full Text] [Related]
4. Potential use of statins to prevent atrial fibrillation after coronary artery bypass surgery. Howard PA; Barnes BJ Ann Pharmacother; 2008 Feb; 42(2):253-8. PubMed ID: 18198239 [TBL] [Abstract][Full Text] [Related]
5. Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation. Coleman CI; Makanji S; Kluger J; White CM Ann Pharmacother; 2007 Mar; 41(3):433-7. PubMed ID: 17341525 [TBL] [Abstract][Full Text] [Related]
6. Effects of preoperative statin treatment on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Miceli A; Fino C; Fiorani B; Yeatman M; Narayan P; Angelini GD; Caputo M Ann Thorac Surg; 2009 Jun; 87(6):1853-8. PubMed ID: 19463608 [TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalization for coronary artery disease. Singh JP; Kulik A; Levin R; Ellinor PT; Ruskin J; Avorn J; Choudhry NK Europace; 2012 Sep; 14(9):1287-93. PubMed ID: 22539600 [TBL] [Abstract][Full Text] [Related]
9. The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials. Madrid AH; Peng J; Zamora J; Marín I; Bernal E; Escobar C; Muños-Tinoco C; Rebollo JM; Moro C Pacing Clin Electrophysiol; 2004 Oct; 27(10):1405-10. PubMed ID: 15511250 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines. Gales BJ; Bailey EK; Reed AN; Gales MA Ann Pharmacother; 2010 Feb; 44(2):360-6. PubMed ID: 20086184 [TBL] [Abstract][Full Text] [Related]
11. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
12. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias. Makkar KM; Sanoski CA; Spinler SA Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795 [TBL] [Abstract][Full Text] [Related]
13. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study. Schaer BA; Schneider C; Jick SS; Conen D; Osswald S; Meier CR Ann Intern Med; 2010 Jan; 152(2):78-84. PubMed ID: 20083826 [TBL] [Abstract][Full Text] [Related]
14. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation. Richter B; Derntl M; Marx M; Lercher P; Gössinger HD Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648 [TBL] [Abstract][Full Text] [Related]
15. Should all patients be treated with an angiotensin-converting enzyme inhibitor after coronary artery bypass graft surgery? The impact of angiotensin-converting enzyme inhibitors, statins, and β-blockers after coronary artery bypass graft surgery. Kalavrouziotis D; Buth KJ; Cox JL; Baskett RJ Am Heart J; 2011 Nov; 162(5):836-43. PubMed ID: 22093199 [TBL] [Abstract][Full Text] [Related]
16. Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications. Lévy S Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):220-5. PubMed ID: 16568131 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations. Epstein BJ; Gums JG Ann Pharmacother; 2005 Mar; 39(3):470-80. PubMed ID: 15701766 [TBL] [Abstract][Full Text] [Related]
18. Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling. Healey JS; Morillo CA; Connolly SJ Curr Opin Cardiol; 2005 Jan; 20(1):31-7. PubMed ID: 15596957 [TBL] [Abstract][Full Text] [Related]
19. Prevention of postoperative atrial fibrillation in open heart surgery patients by preoperative supplementation of n-3 polyunsaturated fatty acids: an updated meta-analysis. Costanzo S; di Niro V; Di Castelnuovo A; Gianfagna F; Donati MB; de Gaetano G; Iacoviello L J Thorac Cardiovasc Surg; 2013 Oct; 146(4):906-11. PubMed ID: 23587470 [TBL] [Abstract][Full Text] [Related]
20. Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction. Ozaydin M; Varol E; Türker Y; Peker O; Erdoğan D; Doğan A; Ibrişim E Anadolu Kardiyol Derg; 2010 Apr; 10(2):137-42. PubMed ID: 20382613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]